Tuesday, June 1, 2021

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug Lilly said it is engaged in active dialogue with the Indian government and regulatory authorities to donate bamlanivimab and etesevimab in order to speed up access and provide treatment options for patients with COVID-19.

from Moneycontrol Business News https://ift.tt/3p6Q9cZ

No comments:

Post a Comment

Adani Group stocks slide up to 14% on US SEC heat

Adani Group stocks saw a sharp decline on Friday. This followed news that the US SEC is seeking court permission to email summons to founder...